Relationship of injection drug use, antiretroviral therapy resistance, and genetic diversity in the HIV-1 pol gene - Wikidata - awgldk - TriplyDB

Relationship of injection drug use, antiretroviral therapy resistance, and genetic diversity in the HIV-1 pol gene

Relationship of injection drug use, antiretroviral therapy resistance, and genetic diversity in the HIV-1 pol gene

http://www.wikidata.org/entity/Q34118276

about

HIV-1 protease inhibitor drug resistance in Kenyan antiretroviral treatment-naive and -experienced injection drug users and non-drug users.

P2860

Q35957224-3673B868-35E3-4C2B-BAFE-7D0071614CE7

P2860

Relationship of injection drug use, antiretroviral therapy resistance, and genetic diversity in the HIV-1 pol gene

http://www.wikidata.org/entity/Q34118276

description

2009 nî lūn-bûn

@nan

2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Relationship of injection drug ...... iversity in the HIV-1 pol gene

@ast

Relationship of injection drug ...... iversity in the HIV-1 pol gene

@en

Relationship of injection drug ...... iversity in the HIV-1 pol gene

@nl

type

label

Relationship of injection drug ...... iversity in the HIV-1 pol gene

@ast

Relationship of injection drug ...... iversity in the HIV-1 pol gene

@en

Relationship of injection drug ...... iversity in the HIV-1 pol gene

@nl

prefLabel

Relationship of injection drug ...... iversity in the HIV-1 pol gene

@ast

Relationship of injection drug ...... iversity in the HIV-1 pol gene

@en

Relationship of injection drug ...... iversity in the HIV-1 pol gene

@nl

P1433

Q34118276-3387E79F-64F3-4FAE-ACA6-4482611A6009

P1476

Q34118276-52BF537C-1C0D-4415-BEAC-8A693A76D2C4

P2093

Q34118276-0CB776F1-0DBB-4A3D-87DE-C0CB4CFD40AD

Q34118276-2198D280-36F4-4F53-AADE-4BFAE875ECAE

Q34118276-23845894-72F8-43EC-BB6A-39D743F29AC8

Q34118276-64FA6D48-7F0C-4400-A377-A18C4F6F4C9D

Q34118276-80DF520F-8BB7-4A64-8ABA-607F97454436

Q34118276-9FC215D4-168F-482F-97EB-37DA9FFD6EDB

Q34118276-FF48F14D-A5C2-4943-9409-2D883EA85E14

P2860

Q34118276-03A77FD2-6B34-46A8-AB0A-D87AB3AC1DEB

Q34118276-0793DD89-840E-47CC-8903-3E935320F492

Q34118276-086BC0F0-0648-435C-BB9E-502CF4E4D934

Q34118276-08D998B1-F316-4C23-B3C6-85265BE6021E

Q34118276-0AAC22B3-39D8-49A8-886B-035E2D6DDD8F

Q34118276-0EA71AD2-16B3-488A-9BF6-10461B028015

Q34118276-0FE16907-8B50-44DC-8609-B81281F73BB1

Q34118276-18C67D60-6053-4569-9AD9-5F67040D0DA9

Q34118276-374D5E20-CCE7-4747-8847-466C51E2BC53

Q34118276-3A057FB7-2F33-4383-9562-6E0368D1FD82

P304

Q34118276-BB43ACC9-270A-47B5-864B-887F47E86DBF

P31

Q34118276-A49478F9-A585-4CB5-84E4-EF6F197C3093

P356

Q34118276-0F6DF6DF-EDC6-46DF-B02B-34727311CEEC

P407

Q34118276-A97EEA94-AC3A-41B0-B2E1-46CDEE6BD3AA

P433

Q34118276-D40D5E89-EFE1-4D30-8AF2-0A116338B23B

P478

Q34118276-731DC4C1-99F3-48AB-B202-AB7BE4440369

P50

Q34118276-11EEF0FE-B27F-4802-AEDF-005CC195E49B

Q34118276-36E468F9-87A9-4EDC-851E-B0E6CC7A65E0

Q34118276-AA510E52-DE4F-4896-87DE-91ECCCA517D9

P577

Q34118276-3F4BAD6E-EFFB-452B-908E-7556025D36D4

P698

Q34118276-062CDE89-55DA-4D51-AF99-72FC55B10E42

P932

Q34118276-229D6AAB-6810-4D95-9CD4-A93E9395582A

P356

QAI.0B013E318198A619

P1433

Journal of Acquired Immune Deficiency Syndromes

P1476

Relationship of injection drug ...... iversity in the HIV-1 pol gene

@en

P2093

Guang Wen Zhang

http://www.w3.org/2001/XMLSchema#string

Hua-Ling Tsai

http://www.w3.org/2001/XMLSchema#string

Mary Young

http://www.w3.org/2001/XMLSchema#string

Mei-Fen Yeh

http://www.w3.org/2001/XMLSchema#string

Michael F Schneider

http://www.w3.org/2001/XMLSchema#string

Qiujia Shao

http://www.w3.org/2001/XMLSchema#string

Richard B Markham

http://www.w3.org/2001/XMLSchema#string

P2860

Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis.

Morphine enhances HIV infection of human blood mononuclear phagocytes through modulation of beta-chemokines and CCR5 receptor.

Relative replication fitness of a high-level 3'-azido-3'-deoxythymidine-resistant variant of human immunodeficiency virus type 1 possessing an amino acid deletion at codon 67 and a novel substitution (Thr-->Gly) at codon 69.

Evidence that low-level viremias during effective highly active antiretroviral therapy result from two processes: expression of archival virus and replication of virus.

Persistence and fitness of multidrug-resistant human immunodeficiency virus type 1 acquired in primary infection

Altered drug sensitivity, fitness, and evolution of human immunodeficiency virus type 1 with pol gene mutations conferring multi-dideoxynucleoside resistance.

Accuracy of the TRUGENE HIV-1 genotyping kit.

Drug resistance mutations in HIV-1.

Maintaining the integrity of human immunodeficiency virus sequence databases.

Patterns of HIV-1 evolution in individuals with differing rates of CD4 T cell decline.

P304

381-389

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAI.0B013E318198A619

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P50

Jeanne Kowalski

P577

2009-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19214121

http://www.w3.org/2001/XMLSchema#string

P932

2937199

http://www.w3.org/2001/XMLSchema#string